Indian Pharma Market (IPM) Key Insights for Sep 2014: IPM grew by 578 Crores over Aug 2014 & 1227 Crs over Sep 2013. The Seasonal spike seen in 2012 from July onwards, which peaks in Sep/Oct and comes down in Nov, was not observed last year due to DPCO / NLEM issues. Hence we are entering a phase where on low base of last year, the growth rates are expected to be in strong double digits for the next 3-4 months. Source: AIOCD Pharmasofttech AWACS

1. Val
in
Crs
MAT MTH Val
(Cr) MS% GR% Val
(Cr) MS% GR% CORPORATE
80565 100.00 9.1 7738 100.00 18.8 IPM
1 1 5030 6.24 5.8 467 6.03 16.7 Abbott
+
Abbott
HC
+
Novo
2 3 4343 5.39 15.0 378 4.89 8.9 Sun
Pharma
3 2 4038 5.01 10.3 427 5.51 38.4 Cipla
4 4 3480 4.32 8.0 312 4.03 12.0 Zydus
+
Biochem
5 7 2908 3.61 4.9 273 3.53 15.8 Ranbaxy
6 5 2899 3.60 10.2 305 3.95 30.9 Mankind
7 6 2887 3.58 13.8 290 3.75 19.1 Alkem
+
Cachet
+
Indchemie
8 8 2729 3.39 -­‐11.1 264 3.41 14.9 Glaxo
9 9 2710 3.36 12.8 259 3.35 19.7 Lupin
10 12 2348 2.91 6.3 229 2.96 23.9 Pfizer
11 10 2279 2.83 21.4 244 3.15 44.2 Macleods
12 14 2193 2.72 11.1 191 2.47 4.9 Emcure
+
Zuventus
13 13 2098 2.60 15.3 195 2.51 18.8 Intas
14 11 2023 2.51 19.9 230 2.98 39.7 Aristo
15 16 1984 2.46 -­‐0.5 180 2.32 13.2 Sanofi
India
16 18 1779 2.21 5.4 167 2.15 18.4 Torrent
17 15 1754 2.18 16.6 185 2.39 27.0 Glenmark
18 17 1719 2.13 9.4 167 2.15 17.5 Dr.
Reddys
19 20 1616 2.01 12.0 143 1.85 4.6 Micro
+
Bal
20 19 1470 1.82 24.7 152 1.96 22.1 Ipca
21 21 1466 1.82 10.0 128 1.66 7.6 USV
22 23 1145 1.42 -­‐1.0 105 1.36 13.4 Novartis
23 22 1103 1.37 12.8 117 1.51 30.6 Alembic
24 25 993 1.23 6.1 84 1.09 7.6 Wockhardt
25 24 843 1.05 6.8 90 1.16 24.0 FDC
26 26 815 1.01 10.7 77 0.99 13.0 Unichem
27 27 794 0.99 12.9 70 0.90 10.0 MSD
+
Fulford
+
Organon
28 29 687 0.85 16.0 60 0.78 9.6 Cadila
29 28 633 0.79 13.4 68 0.88 34.4 Indoco
Remedies
30 30 590 0.73 12.5 56 0.73 13.1 Franco
31 31 581 0.72 18.1 49 0.64 12.2 Eris
32 33 491 0.61 8.3 48 0.62 17.2 Himalaya
33 32 483 0.60 10.4 48 0.62 21.6 Merck
34 34 441 0.55 6.3 47 0.60 27.1 Blue
Cross
35 36 441 0.55 16.6 45 0.58 41.5 JB
Chemicals
36 38 398 0.49 -­‐6.4 43 0.55 49.9 Bharat
Serums
37 47 396 0.49 -­‐0.2 30 0.38 -­‐18.0 Astrazeneca
38 39 391 0.49 22.6 38 0.50 23.9 Meyer
Organics
39 40 385 0.48 2.4 37 0.48 12.8 Raptakos,
Brett
40 35 384 0.48 50.9 46 0.60 92.5 Akumentis
41 37 373 0.46 16.6 44 0.57 48.2 Hetero
42 43 372 0.46 9.8 35 0.45 12.1 Wallace
+
Indi
Pharma
43 42 353 0.44 16.1 36 0.47 26.9 Medley
44 46 342 0.42 10.8 31 0.40 18.8 Janssen
45 44 338 0.42 2.6 33 0.43 13.6 Win-­‐Medicare
46 45 332 0.41 10.7 32 0.41 14.4 Fourrts
47 49 315 0.39 38.4 28 0.37 35.9 Ajanta
48 48 310 0.39 41.7 29 0.38 22.1 Biocon
With
Bonus
Units
at
Full
Value
Rank MAT
Sep
-­‐14 Sep-­‐14

2. 49 41 309 0.38 33.0 36 0.47 62.2 Apex
Lab
50 51 301 0.37 5.6 27 0.35 -­‐2.3 Albert
David

3. MAT MTH Val
(Cr) MS% GR% Val
(Cr) MS% GR%
77530 100.00 9.2 7421 100.00 18.6
1 1 4934 6.36 5.8 457 6.15 16.9
2 3 4241 5.47 14.2 368 4.95 8.1
3 2 3799 4.90 12.6 399 5.38 38.7
4 4 3254 4.20 7.7 292 3.94 11.1
5 7 2799 3.61 5.2 262 3.53 15.8
9 6 2475 3.19 12.1 265 3.57 33.7
7 5 2692 3.47 14.5 270 3.64 20.0
6 8 2704 3.49 -­‐10.1 262 3.53 15.5
8 9 2654 3.42 13.0 254 3.42 20.3
10 11 2298 2.96 6.7 224 3.02 23.9
11 10 2135 2.75 21.2 226 3.05 43.9
12 14 2127 2.74 11.4 184 2.48 4.7
13 13 2070 2.67 15.6 192 2.59 19.0
15 12 1772 2.29 17.4 198 2.67 36.1
14 16 1944 2.51 -­‐0.7 175 2.36 12.5
16 17 1744 2.25 5.7 163 2.20 18.3
17 15 1701 2.19 16.2 179 2.41 26.4
18 18 1682 2.17 8.6 162 2.18 16.7
19 20 1546 1.99 12.5 136 1.83 4.1
21 19 1404 1.81 25.0 145 1.95 22.5
20 21 1460 1.88 10.1 128 1.72 7.8
22 23 1108 1.43 0.0 102 1.38 14.3
23 22 1072 1.38 13.5 114 1.53 31.3
24 25 974 1.26 6.2 83 1.11 7.4
25 24 819 1.06 6.7 87 1.18 24.0
26 26 797 1.03 10.3 75 1.01 12.8
27 27 783 1.01 12.6 68 0.92 9.5
28 29 665 0.86 16.1 58 0.78 9.2
29 28 593 0.76 13.4 63 0.85 33.7
31 30 569 0.73 11.9 54 0.73 12.6
30 31 578 0.74 17.9 49 0.66 12.4
32 32 489 0.63 8.0 48 0.64 17.0
33 33 471 0.61 9.4 46 0.63 21.1
35 36 405 0.52 7.1 42 0.57 26.5
34 35 424 0.55 16.7 43 0.59 42.4
37 37 391 0.50 -­‐6.8 42 0.57 49.5
36 47 392 0.51 -­‐0.6 29 0.40 -­‐17.7
39 39 379 0.49 22.4 37 0.50 23.4
38 40 379 0.49 2.2 37 0.50 12.9
40 34 377 0.49 52.4 46 0.61 94.0
43 38 339 0.44 16.7 40 0.54 46.7
41 43 353 0.46 17.4 34 0.46 22.3
44 42 335 0.43 16.4 34 0.46 26.8
42 45 341 0.44 10.8 31 0.42 18.8
45 44 333 0.43 1.2 33 0.44 13.1
46 46 316 0.41 9.7 30 0.40 12.8
47 49 313 0.40 38.2 28 0.38 35.8
48 48 310 0.40 41.7 29 0.39 22.1
Without
Bonus
Units
Rank MAT
Sep
-­‐14 Sep-­‐14

4. 49 41 300 0.39 33.1 35 0.48 64.3
50 51 295 0.38 5.4 27 0.36 -­‐2.8